2021 Emerging Cancer Diagnostic Technologies and Strategic Profiles of Leading Suppliers

This 185-page report provides detailed assessments of such technologies as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for cancer diagnostic testing. Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics spectroscopy.

The report also presents strategic assessments of current and emerging suppliers of cancer diagnostic products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.

Contains 185 pages

Chromosome Analysis
a. Chronic Myelogenous Leukemia (CML)
b. Acute Myeloid Leukemia (AML)
c. Acute Lymphoblastic Leukemia (ALL)
d. Malignant Lymphomas Lymphoid Malignancies
e. Chronic Lymphocytic Leukemia (CLL)
f. Solid Cancers
g. Chromosomal Translocation and Oncogenes
Artificial Intelligence
Flow Cytometry
Two Dimensional Gel Electrophoresis (2-DGE)
Biosensors
Competing/Complementing Technologies
a. CT b.
MRI c.
NMR d.
PET
e. Photonics Spectroscopy
Competitive Profiles
The report provides strategic assessments of over 30 leading cancer diagnostics
market players and start-up companies with innovative technologies and
products, including:
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
Table of Contents (continued)
- Fujirebio
- Grifols
- Hologic
- Leica Biosystems
- Ortho-Clinical Diagnostics
- PerkinElmer
- Qiagen
- Roche
- Siemens Healthineers
- Takara Bio
- Thermo Fisher
- Wako and others.

Global Neuromodulation Devices Market Outlook 2021: Global Opportunity and Demand Analysis, Market Forecast to 2030

The neuromodulation devices market is anticipated to grow at a CAGR of 6.5% over the forecast period of 20202028. According to a study published by Insure Insights on the neuromodulation

USD 3950 View Report

Global Neuromarketing Solutions Market Outlook 2021: Global Opportunity and Demand Analysis, Market Forecast, 2022-2030

The Global Neuromarketing Solutions market is anticipated to rise at a value CAGR of 9.65% over 20202028. According to a study published by Insure Insights on the Global Neuromarketing Solutions

USD 3950 View Report

2021 Emerging Clinical Chemistry and Immunodiagnostic Technologies, and Strategic Profiles of Leading Suppliers

This 145-page report reviews potential market applications of current and emerging clinical chemistry and immunodiagnostic technologies, including monoclonal and polyclonal antibodies, immunoassays,  IT, dry chemistry, biosensors, robotics, molecular diagnostics and

USD 2450 View Report

2021 Emerging Coagulation Testing Technologies and Strategic Profiles of Leading Suppliers

This 124-page report provides assessments of such technologies as chromogenic substrates, monoclonal and polyclonal antibodies, immunoassays, IT, molecular diagnostics, and their potential applications for coagulation testing.The report also includes strategic

USD 2450 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available